全文获取类型
收费全文 | 35533篇 |
免费 | 1667篇 |
国内免费 | 202篇 |
专业分类
耳鼻咽喉 | 339篇 |
儿科学 | 803篇 |
妇产科学 | 485篇 |
基础医学 | 4687篇 |
口腔科学 | 939篇 |
临床医学 | 2288篇 |
内科学 | 9253篇 |
皮肤病学 | 741篇 |
神经病学 | 2616篇 |
特种医学 | 1197篇 |
外科学 | 6245篇 |
综合类 | 156篇 |
一般理论 | 3篇 |
预防医学 | 1051篇 |
眼科学 | 412篇 |
药学 | 2563篇 |
中国医学 | 113篇 |
肿瘤学 | 3511篇 |
出版年
2023年 | 182篇 |
2022年 | 350篇 |
2021年 | 606篇 |
2020年 | 310篇 |
2019年 | 446篇 |
2018年 | 572篇 |
2017年 | 538篇 |
2016年 | 576篇 |
2015年 | 573篇 |
2014年 | 795篇 |
2013年 | 984篇 |
2012年 | 1575篇 |
2011年 | 1660篇 |
2010年 | 998篇 |
2009年 | 856篇 |
2008年 | 1558篇 |
2007年 | 1744篇 |
2006年 | 1724篇 |
2005年 | 1821篇 |
2004年 | 1736篇 |
2003年 | 1743篇 |
2002年 | 1651篇 |
2001年 | 1227篇 |
2000年 | 1304篇 |
1999年 | 1153篇 |
1998年 | 512篇 |
1997年 | 350篇 |
1996年 | 350篇 |
1995年 | 331篇 |
1994年 | 286篇 |
1993年 | 285篇 |
1992年 | 799篇 |
1991年 | 732篇 |
1990年 | 699篇 |
1989年 | 762篇 |
1988年 | 657篇 |
1987年 | 619篇 |
1986年 | 550篇 |
1985年 | 531篇 |
1984年 | 345篇 |
1983年 | 288篇 |
1979年 | 272篇 |
1978年 | 192篇 |
1977年 | 166篇 |
1974年 | 159篇 |
1973年 | 173篇 |
1972年 | 169篇 |
1971年 | 157篇 |
1970年 | 155篇 |
1969年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
S. Shimizu T. Onoe K. Ishiyama K. Ide M. Ohira H. Tahara Y. Saeki T. Kobayashi S. Kuroda H. Tashiro H. Ohdan 《Transplantation proceedings》2014
Maintaining hepatic inflow and appropriate venous drainage is important for maximizing the capacity of the retrieved graft in liver transplantation. Here, we report a successful case of multiple hepatic vein (HV) reconstruction using an all-in-one sleeve patch graft of the autologous great saphenous vein to ensure adequate blood flow through the HV. A patient with hepatocellular carcinoma caused by hepatitis C virus–induced cirrhosis underwent living donor liver transplantation using a right lobe graft. A preoperative dynamic computed tomography scan and intraoperative findings revealed that the graft had three middle HV tributaries, a superficial vein, segment VIII HV (V8), and segment V HV (V5). The openings of the superficial vein and V8 were located very close to that of the right hepatic vein (RHV) in the cutting surface. Each HV had significant diameter and drainage territory requiring reconstruction. An autologous great saphenous vein was used to create a sleeve patch to incorporate the close-packed HV openings. The autologous sleeve patch graft was sutured to the openings of the RHV and the superficial vein and the hole created on the sleeve patch graft was anastomosed to the openings of V8 directly on the back table to create an all-in-one sleeve patch. For the V5 reconstruction, the recipient's intrahepatic portal vein graft was used to create an interpositional conduit from the recipient's V5 to the inferior vena cava. The postoperative course was uneventful and postoperative studies revealed good graft function with excellent blood flow in the HV. 相似文献
993.
A. Mita T. Ikegami Y. Masuda Y. Katsuyama Y. Ohno K. Urata Y. Nakazawa A. Kobayashi S. Miyagawa 《Transplantation proceedings》2014
Introduction
Once-daily extended-release tacrolimus (Tac-OD) is expected to reduce non-adherence in recipients after liver transplantation (LT). The aim of this study was to determine the optimal initial dose of orally administered Tac-OD after intravenous tacrolimus (Tac-IV) therapy after LT.Patients and Methods
This prospective study included 10 adult recipients who had undergone LT at our institute. The recipients were prescribed tacrolimus by continuous intravenous administration with a steroid as initial immunosuppression therapy. Tacrolimus was converted from intravenous administration to once-daily oral intake when gastrointestinal function returned. We evaluated tacrolimus concentrations in blood 9 times a day and area under the blood concentration−time curve (AUC) during conversion. The optimal initial dose of Tac-OD was determined based on simple regression analysis between the oral dose of Tac-OD and the total dose of Tac-IV during a 24-hour period.Results
The AUC before and after conversion showed no differences. We found that the optimal initial dose of Tac-OD was 8 times the dose of Tac-IV. There was a relationship between the AUC and the trough level. No recipients experienced acute rejection or adverse effects such as renal failure, neurotoxicity, or cardiac failure during conversion.Conclusions
We successfully converted continuous Tac-IV to oral intake of Tac-OD by adjusting the dose using trough levels without acute rejection or adverse effects. The AUC of Tac-OD correlated with the trough level. The optimal initial dose ratio of Tac-OD after Tac-IV was 8:1. 相似文献994.
995.
996.
Keita Itatsu Gen Sugawara Yuji Kaneoka Takehito Kato Eiji Takeuchi Michio Kanai Hiroshi Hasegawa Toshiyuki Arai Yukihiro Yokoyama Masato Nagino 《Surgery today》2014,44(7):1242-1252
Purpose
An incisional surgical site infection (I-SSI) is a frequently observed complication following colorectal surgery. Intraoperative wound management is one of the most important factors that determine the incidence of postoperative I-SSI. The purpose of this study was to assess the impact of the methods used for intraoperative wound management on the incidence of I-SSI following elective surgery for colorectal cancer.Methods
Between November 2009 and February 2011, the data of 1,980 consecutive patients who underwent elective colorectal resection for colorectal cancer were prospectively collected from 19 affiliated hospitals. The incidence of and risk factors for I-SSI were investigated.Results
Overall, 233 I-SSIs were identified (11.7 %). Forty-two possible risk factors were analyzed. Using a multivariate analysis, the independent risk factors for I-SSI were identified to be a high body mass index, previous laparotomy, chronic liver disease, wound length, contaminated wound class, creation or closure of an ostomy, right hemicolectomy procedure, the suture material used for fascial closure and the incidence of organ/space SSI.Conclusion
To prevent I-SSI following elective colorectal surgery, it is crucial to avoid making large incisions and reduce fecal contamination whenever possible. A high quality randomized control trial is necessary to confirm the definitive intraoperative procedure(s) that can minimize the incidence of I-SSI. 相似文献997.
998.
Mari Akiyama Katsuhiro Kobayashi Takushi Inoue Tomoyuki Akiyama Harumi Yoshinaga 《Brain & development》2014
Purpose: Ictal fear is an uncommon condition in which fear manifests as the main feature of epileptic seizures. The literature has suggested that ictal fear is generally associated with poor seizure outcomes. We wanted to clarify the variability in seizure outcome of children with ictal fear. Subjects and methods: We identified five pediatric patients with ictal fear who were followed up on at Okayama University Hospital between January 2003 and December 2012. We retrospectively reviewed their clinical records and EEG findings. Results: The onset age of epilepsy ranged from 8 months to 9 years and 10 months. The common ictal symptoms were sudden fright, clinging to someone nearby, and subsequent impairment of consciousness, which were often accompanied by complex visual hallucinations and psychosis-like complaints. Ictal fear, in four patients, was perceived as a nonepileptic disorder by their parents. Ictal electroencephalograms (EEG) of ictal fear were obtained in all patients. Three showed frontal onset, while the other two showed centrotemporal or occipital onsets. Two patients were seizure free at last follow-up, while seizures persisted in the other three. A patient with seizure onset during infancy had a favorable outcome, which was considered to be compatible with benign partial epilepsy with affective symptoms. Conclusion: Ictal fear is not always associated with a symptomatic cause or a poor seizure outcome. It is quite important to make a correct diagnosis of ictal fear as early as possible to optimize treatment. 相似文献
999.
Hiroyuki Torisu Kyoko Watanabe Keiko Shimojima Midori Sugawara Masafumi Sanefuji Yoshito Ishizaki Yasunari Sakai Hironori Yamashita Toshiyuki Yamamoto Toshiro Hara 《Brain & development》2014
This paper documents the case of a female Japanese patient with infantile focal epilepsy, which was different from benign infantile seizures, and a family history of infantile convulsion and paroxysmal choreoathetosis. The patient developed partial seizures (e.g., psychomotor arrest) at age 14 months. At the time of onset, interictal electroencephalography (EEG) showed bilateral parietotemporal spikes, but the results of neurologic examination and brain magnetic resonance imaging were normal. Her seizures were well controlled with carbamazepine, and she had a normal developmental outcome. EEG abnormalities, however, persisted for more than 6 years, and the spikes moved transiently to the occipital area and began to resemble the rolandic spikes recognized in benign childhood epilepsy. Her father had paroxysmal kinesigenic dyskinesia, with an onset age of 6 years, and her youngest sister had typical benign infantile seizures. Genetic analysis demonstrated that all affected members had a heterozygous mutation of c.649_650insC in the proline-rich transmembrane protein-2 (PRRT2) gene. This case indicates that the phenotypic spectrum of infantile seizures or epilepsy with PRRT2-related pathology may be larger than previously expected, and that genetic investigation of the effect of PRRT2 mutations on idiopathic seizures or epilepsy in childhood may help elucidate the pathological backgrounds of benign childhood epilepsy. 相似文献
1000.
Hiroki Sato Mitsugu Uematsu Wakaba Endo Tojo Nakayama Tomoko Kobayashi Naomi Hino-Fukuyo Osamu Sakamoto Haruo Shintaku Shigeo Kure 《Brain & development》2014
Autosomal recessive guanosine triphosphate cyclohydrolase I (GTPCH) deficiency is an inborn error of tetrahydrobiopterin (BH4) synthesis from GTP. GTPCH deficiency causes severe reduction of BH4, resulting in hyperphenylalaninemia (HPA) and decreased dopamine and serotonin synthesis. Without treatment, a patient with GTPCH deficiency develops complex neurological dysfunctions, including dystonia and developmental delays. The first Japanese patient with GTPCH deficiency was discovered by HPA during asymptomatic newborn screening. The phenylalanine level at the age of 5 days was 1273 μmol/L (cutoff value, 180.0 μmol/L). The high serum phenylalanine level was decreased to normal after adequate BH4 oral supplementation. Serum and urinary pteridine examination revealed very low levels of neopterin and biopterin. Sequence analysis of GCH1 revealed compound heterozygous point mutations, including a novel point mutation (p.R235W). Replacement therapy with BH4 and L-dopa/carbidopa were started at the age of 1 month, and 5-hydroxytryptophan (5-HTP) was started at the age of 5 months. At 10 months of age, the patient showed slight dystonia but no obvious developmental delay. Cerebrospinal fluid should be examined to determine the appropriate dosage of supplement drugs. In conclusion, it is important to control the serum phenylalanine level and perform early replacement of neurotransmitters to prevent neurological dysfunction. 相似文献